288 related articles for article (PubMed ID: 3501504)
21. [C-reactive protein (CRP) as a marker of of hemodialysis biocompatibility].
Szepietowski T; Krajewska M
Polim Med; 1997; 27(1-2):47-59. PubMed ID: 9380601
[TBL] [Abstract][Full Text] [Related]
22. Clinical sequelae of complement activation in hemodialysis.
Hakim RM
Clin Nephrol; 1986; 26 Suppl 1():S9-12. PubMed ID: 3829474
[TBL] [Abstract][Full Text] [Related]
23. Research on dialyzers with improved biocompatibility.
van der Steen A
Clin Nephrol; 1986; 26 Suppl 1():S39-42. PubMed ID: 3829466
[TBL] [Abstract][Full Text] [Related]
24. The influence of dialyzer geometry on blood coagulation and biocompatibility.
Lins LE; Boberg U; Jacobson SH; Kjellstrand C; Ljungberg B; Skröder R
Clin Nephrol; 1993 Nov; 40(5):281-5. PubMed ID: 8281717
[TBL] [Abstract][Full Text] [Related]
25. Modified cellulosic dialyzer membranes: an investigative tool in thrombogenicity studies.
Mahiout A; Meinhold H; Kessel M; Vienken J; Baurmeister U
ASAIO Trans; 1988; 34(3):878-81. PubMed ID: 3058187
[TBL] [Abstract][Full Text] [Related]
26. Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes.
Chenoweth DE; Cheung AK; Henderson LW
Kidney Int; 1983 Dec; 24(6):764-9. PubMed ID: 6609269
[TBL] [Abstract][Full Text] [Related]
27. On the mechanisms of haemodialysis-induced neutropenia: a study with five new and re-used membranes.
Heierli C; Markert M; Lambert PH; Kuwahara T; Wauters JP
Nephrol Dial Transplant; 1988; 3(6):773-83. PubMed ID: 3147419
[TBL] [Abstract][Full Text] [Related]
28. [Clinical study of biocompatibility of dialysis membranes made from non-modified and modified cellulose].
Opatrný K; Sulková S; Vít L; Vienken J; Körwer-Uhlenbusch I; Sefrna F; Válek A; Bláha J
Cas Lek Cesk; 1992 Aug; 131(15):457-61. PubMed ID: 1423453
[TBL] [Abstract][Full Text] [Related]
29. Biocompatibility of hemodialysis membranes: a study in healthy subjects.
Gutierrez A; Alvestrand A; Bergström J; Beving H; Lantz B; Henderson LW
Blood Purif; 1994; 12(2):95-105. PubMed ID: 7826580
[TBL] [Abstract][Full Text] [Related]
30. Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation.
Wiegmann TB; MacDougall ML; Diederich DA
Am J Kidney Dis; 1988 May; 11(5):418-24. PubMed ID: 3259402
[TBL] [Abstract][Full Text] [Related]
31. [Evaluation of the biocompatibility of a new cellulose membrane by studying the complement system and histamine liberation].
Tridon A; Deteix P; Coves G; Cluzel P; Marqués Verdier A; Wauquier JP; Bétail G; Baguet JC
Nephrologie; 1987; 8(4):217-21. PubMed ID: 2447516
[TBL] [Abstract][Full Text] [Related]
32. [The effect of the primary and repeated use of dialyzers with different membranes on the degree of dialysis-induced leukopenia].
Strokov AG; Baeva LB; Levitskiĭ ER
Med Tekh; 1990; (5):16-8. PubMed ID: 2273963
[TBL] [Abstract][Full Text] [Related]
33. Chemical modification of cellulosic membranes and their blood compatibility.
Paul D; Malsch G; Bossin E; Wiese F; Thomaneck U; Brown GS; Werner H; Falkenhagen D
Artif Organs; 1990 Apr; 14(2):122-5. PubMed ID: 2350257
[TBL] [Abstract][Full Text] [Related]
34. Effects of a polyelectrolyte additive on the selective dialysis membrane permeability for low-molecular-weight proteins.
Krieter DH; Morgenroth A; Barasinski A; Lemke HD; Schuster O; von Harten B; Wanner C
Nephrol Dial Transplant; 2007 Feb; 22(2):491-9. PubMed ID: 17050637
[TBL] [Abstract][Full Text] [Related]
35. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
[No Abstract] [Full Text] [Related]
36. Synthetically modified cellulose: an alternative to synthetic membranes for use in haemodialysis?
Hoenich NA; Woffindin C; Stamp S; Roberts SJ; Turnbull J
Biomaterials; 1997 Oct; 18(19):1299-303. PubMed ID: 9307219
[TBL] [Abstract][Full Text] [Related]
37. Cellulose membranes--time for a change?
Henderson LW; Chenoweth DE
Contrib Nephrol; 1985; 44():112-26. PubMed ID: 3872769
[No Abstract] [Full Text] [Related]
38. Biocompatibility of dialysis membranes: effects of chronic complement activation.
Hakim RM; Fearon DT; Lazarus JM
Kidney Int; 1984 Aug; 26(2):194-200. PubMed ID: 6334194
[TBL] [Abstract][Full Text] [Related]
39. Effects of complement activation by hemodialysis membranes.
Cheung AK; Henderson LW
Am J Nephrol; 1986; 6(2):81-91. PubMed ID: 3518458
[No Abstract] [Full Text] [Related]
40. The design of cellulosic based membranes that do not activate complement.
Johnson RJ
Med Prog Technol; 1989; 15(1-2):77-81. PubMed ID: 2530429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
